Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Resuscitation
- Vol. 139, 214-221
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland
- Maire Jokinen’s foundation
This publication has 37 references indexed in Scilit:
- Modeling Serum Level of S100β and Bispectral Index to Predict Outcome After Cardiac ArrestJACC, 2013
- Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort studyBMC Cardiovascular Disorders, 2011
- Serum levels of S100B and NSE proteins in Alzheimer's disease patientsJournal of Neuroinflammation, 2010
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Cerebrospinal fluid and serum neuron‐specific enolase concentrations in a normal population*European Journal of Neurology, 2005
- Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With HypothermiaStroke, 2003
- Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases.Stroke, 1994
- Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarctionEuropean Journal of Clinical Investigation, 1991
- Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.Thorax, 1985
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical ScaleThe Lancet, 1975